Results 251 to 260 of about 42,534 (266)

Inhibition of HIV-1 virion production by a transdominant mutant of integrase interactor 1

Nature Medicine, 2001
Eric Yung, Olivier O Delattre, Ganjam V Kalpana   +2 more
exaly  

Resistance to HIV-1 integrase inhibitors: A structural perspective

Drug Resistance Updates, 2010
Jean-François Mouscadet, Anne Geneviève Marcelin, Luba Tchertanov   +2 more
exaly  

Structure of a two-domain fragment of HIV-1 integrase: implications for domain organization in the intact protein

EMBO Journal, 2001
Wei Yang, Hong Ling, Robert Craigie
exaly  

Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study

Lancet, The, 2013
Carlo Torti, Chloe Orkin, Mark Bloch
exaly  

Critical contacts between HIV-1 integrase and viral DNA identified by structure-based analysis and photo-crosslinking

EMBO Journal, 1997
Dominic Esposito, Alan N Engelman, Robert Craigie   +2 more
exaly  

Integrase polymorphism and HIV-1 group O diversity

AIDS, 2008
Marie, Leoz, Agnès, Depatureaux, Aurélia, Vessière, Bénédicte, Roquebert, Florence, Damond, Dominique, Rousset, Pierre, Roques, François, Simon, Jean-Christophe, Plantier   +8 more
openaire   +2 more sources

Sequence specificity of viral end DNA binding by HIV-1 integrase reveals critical regions for protein-DNA interaction

EMBO Journal, 1998
Dominic Esposito, Robert Craigie
exaly  

Acetylation of HIV-1 integrase by p300 regulates viral integration

EMBO Journal, 2005
Anna Cereseto, Lara Manganaro, Marina Lusic   +2 more
exaly  

Raltegravir with Optimized Background Therapy for Resistant HIV-1 Infection

New England Journal of Medicine, 2008
Mauro Schechter, Jeffrey L Lennox, Jose M Gatell   +2 more
exaly  

Multimode, Cooperative Mechanism of Action of Allosteric HIV-1 Integrase Inhibitors

Journal of Biological Chemistry, 2012
Alison Slaughter, Alan N Engelman, James R Fuchs   +2 more
exaly